One targets liver scarring, one aims to stop diabetes before it starts, and a third is starting a mid-stage trial against tirzepatide.
Three GLP-1 drugs are being tested for liver…
One targets liver scarring, one aims to stop diabetes before it starts, and a third is starting a mid-stage trial against tirzepatide.